The propagules of the fungal species Cryptococcus neoformans and C. gattii, whose varieties are distributed world wide, are the primary cause of cryptococcosis, a life threatening disease. The study of environmental and clinical isolates of Cryptococcosis is an important contribution to the epidemiology and ecology of the fungus. The aim of this work was to determine the presence of C. neoformans and C. gattii in the environment in Bogotá, Colombia's capital city and to establish the relation between clinical and environmental isolates in the period 2012-2015. From a total of 4.116 environmental samples collected between October 2012 - March 2014, 35 were positive for C. neoformans var. grubii. From 55 cryptococcosis cases reported in Bogotá during 2012-2015, 49 isolates were recovered. From those, 94% were identified as C. neoformans var. grubii molecular type VNI; 4% as VNII and 1,2% as C. neoformans var neoformans VNIV. The 84 detected clinical and environmental isolates studied had a similarity between 49-100% according with molecular typing. The correlation between environmental and clinical samples confirms the hypothesis that patients acquire the disease from environmental exposure to the fungal propagules.
The propagules of the fungal species Cryptococcus neoformans and C. gattii, whose varieties are distributed world wide, are the primary cause of cryptococcosis, a life threatening disease. The study of environmental and clinical isolates of Cryptococcosis is an important contribution to the epidemiology and ecology of the fungus. The aim of this work was to determine the presence of C. neoformans and C. gattii in the environment in Bogotá, Colombia's capital city and to establish the relation between clinical and environmental isolates in the period 2012-2015. From a total of 4.116 environmental samples collected between October 2012 - March 2014, 35 were positive for C. neoformans var. grubii. From 55 cryptococcosis cases reported in Bogotá during 2012-2015, 49 isolates were recovered. From those, 94% were identified as C. neoformans var. grubii molecular type VNI; 4% as VNII and 1,2% as C. neoformans varneoformans VNIV. The 84 detected clinical and environmental isolates studied had a similarity between 49-100% according with molecular typing. The correlation between environmental and clinical samples confirms the hypothesis that patients acquire the disease from environmental exposure to the fungal propagules.
Cryptococcosis is an opportunistic mycoses of immunosuppressed and immunocompetent
patients. Infection is acquired by inhalation of fungal propagules through environmental
exposure. It is considered a potentially fatal infection of the lungs and the central
nervous system (CNS). The etiological agents are Cryptococcus neoformans
and C. gattii, whose varieties have a worldwide distribution. However, a
recently proposed taxonomy for these species suggests there are seven species in the
complex (Cabral 1999, Cogliati 2013, Hagen et al. 2015).There are two varieties of C. neoformans mainly associated with HIV/AIDSpatients, var. grubii (serotype A), distributed worldwide and var.
neoformans (serotype D) that together with the hybrid AD, are
concentrated in Europe (Viviani et al. 2006, Trilles et al. 2008, Heitman et al. 2011). These species have been isolated mostly from bird excreta,
especially from pigeon, and decaying wood from different trees, except for the serotype D
(Rosario et al. 2008, Trilles et al. 2008, Francis et al.
2013). Studies on the environmental distribution in different parts of the world
have increased, such as in South Africa, Argentina, Brazil, India and Thailand (Ergin et al. 2004, Kuroki et al. 2004, Grover et al. 2007,
Rosario et al. 2008, Trilles et al. 2008, Refojo et al.
2009). C. gattii is grouped into serotypes B and C, distributed
in tropical, subtropical and template regions (Byrnes et al.
2009, Cogliati 2013), and affecting mostly
immunocompetent persons. This species has been recovered from plant debris in trees like
Eucalyptus sp, Terminalia catappa,
Corymbias, among others. C. gattii has been reported
in recent years in Australia, Italy, Spain, Netherlands, Japan, India, Colombia and South
Korea (Granados & Castañeda 2006, Grover et al. 2007, Hagen & Boekhout 2010, Escandón et al.
2010, Colom et al. 2012, Hagen et al. 2012, Cogliati 2013).In Colombia, environmental studies have reported isolates of C. neoformans
var. grubii (serotype A) and C. gattii (serotype B and
serotype C) from plant debris in trees like Eucalyptus sp, T.
catappa, Corymbias and Ficus, and described
that serotypes A and B were the most prevalent (Castañeda
& Castañeda 2001, Granados & Castañeda
2005, Quintero et al. 2005, Escandón et al. 2010). In Bogotá, studies reported
C. neoformans and C. gattii from 192 environmental and
clinical samples, being serotype A the most prevalent, followed by serotype B and C (Ordoñez & Castañeda 1994).In 2001, Castañeda and Castañeda (2001) described the
association between Cryptococcus and Eucalyptus from a
local park in Bogotá, with a positivity of 4% during a two-year sampling period. In 2005,
Granados and Castañeda (2005) collected 480
environmental samples with a positivity of 7.9% for C. neoformans and, in
2010, Escandón et al. (2010) found a positivity of
11.7% for C. gattii isolated from Corymbia ficifolia in
Bogotá.A number of molecular typing techniques have been used to study the molecular epidemiology
of C. neoformans and C. gattii (Meyer et al. 2003), providing more discriminatory power than
conventional techniques (Perfect et al. 1993). Using
polymerase chain reaction (PCR) fingerprinting, eight major molecular types have been
established (Meyer et al. 2003). The major molecular
types VNI and VNII correspond to C. neoformans var.
grubii, being VNI the most prevalent in environmental and clinical
isolates (Springer & Chaturvedi 2010, Cogliati 2013), VNIII corresponds to the AD hybrid and
VNIV (Serotype D) corresponds to C. neoformans var.
neoformans, found mainly in Europe (Viviani et al. 2006).Molecular types VGI, VGII, VGIII and VGIV correspond to C. gattii, whose
environmental and clinical distribution vary according to the region. It has been reported
that molecular type VGI is the most frequent in Australia (Meyer et al. 2003); VGII in Canada, South America and Australia (Byrnes et al. 2009, Cogliati 2013), being the unique to report of an outbreak in Vancouver Island
and in the North of USA (Byrnes et al. 2009); VGIII
is most frequently recovered in South America (Meyer et al.
2003) and VGIV in South Africa and India (Springer & Chaturvedi 2010, Cogliati
2013).In the last report of the Colombian Group for the Study of cryptococcosis, the annual
incidence rate was 3.3x103 cases in AIDSpatients and in the general population
2.4x106, between 2006-2010. This passive surveillance is important for the
study of this opportunistic infection in AIDSpatients, considered a sentinel marker for
HIV infection (Escandón et al. 2012). The aim of
this work was to determine the presence of C. neoformans and C.
gattii in the environment in Bogotá and to establish the genetic relation of
these isolates with those causing cases of cryptococcosis reported during the period
2012-2015.
MATERIALS AND METHODS
Study design - Epidemiological and molecular study from environmental
and clinical isolates in the capital city Bogotá - Colombia.Study area - Bogotá is the capital of Colombia, located at 4º34 N
latitude, 74º00 W longitude, and 2.630 meters above sea level, with an average
temperature of 13.8ºC. A total of 15 areas were chosen and divided in six zones from
north to south in Bogotá. Four areas previously determined to be positive (Granados & Castañeda 2005, Escandón et al. 2010) were included, and the others were chosen due
to a high density of trees (Fig. 1).
Fig. 1
: description of the sampled areas for the recovery of Cryptococcus
neoformans, recovered between October 2012 and March 2014 in the
capital city of Colombia, Map of Bogotá with the six zones.
Clinical isolates - Information on cryptococcosis cases was gathered
retrospectively from a passive surveillance during 2012-2015 from patients residing in
Bogotá.Environmental sampling - The methodology used for sampling was
described by Escandón et al. (2010).
Environmental samples from the hollows, leaves, bark, flowers, soil and fruits of two
tree species, Eucalyptus sp. and Corymbia sp., were
collected during every month between September 2012 and March 2014 (n = 19 months), in
the selected areas previously described. A longitudinal sampling was carried out in
those positive areas for a period of five months from October 2013 - March 2014.Environmental data - Temperature, relative humidity, precipitation and
sunshine in Bogotá during the study period were obtained from the Institute of
Hydrology, Meteorology and Environmental Studies (http://www.ideam.gov.co.).Conventional techniques - Environmental samples were identified by
streaking onto Niger-seed agar as described by Granados and Escandón (Granados & Castañeda 2006, Escandón et al. 2010). Phenotypic tests were used for sample
processing and confirmation of isolates as previously described (Kwon-Chung et al. 1982). DNA was extracted as reported by Escandón et al. (2006) and molecular type was
determined by PCR fingerprinting with the unique primer (GTG)5 and
restriction fragment length polymorphism (RFLP) of the URA5 gene (Meyer et al. 2003, Escandón et al. 2010). PCR products were compared with reference strains
reported and provided by Meyer et al. (2003).The analysis of molecular types generated by PCR-(GTG)5 was performed using
the Gel Compare 2® V.4.0 (Applied Maths, Sint-Martens Latem, Belgium) program. The Dice
coefficient was used to compare the molecular types and establish genetic relationships
between isolates. Clustering was based on the Unweighted Pair Group Method (UPGMA)
algorithm with a tolerance 4.0% and optimisation of 1,5%.
RESULTS
Environmental samples - Out of 4.116 environmental samples collected
from Corymbia sp and Eucalyptus sp in Bogotá from six
different zones (Fig. 1), 35 samples were positive
for C. neoformans (0.9%). Of these positive samples, 20 (57.1%) were
from bark, 13 (37.1%) from soil and two (5.8%) from fruit (Table I). From the positive samples, 110 colonies were recovered all
belonging to C. neoformans var. grubii. C.
gattii was not recovered.
TABLE I
Description of positive samples for Cryptococcus
neoformans recovered between October 2012 and March 2014 in the
capital city of Colombia, according to the type of tree and type of
sample
Corymbia sp
Eucalyptus
Zones
Places
Total of samples
Bark
Bark
Fruit
Soil
Total
Zone 1
Av 19 - 105
4
0
0
0
0
0
Parque 104 - Terpel
165
0
2
0
0
2
Parque 106
10
0
0
0
0
0
Zone 2*
Bavaria
3
0
0
0
0
0
Museo Chico
26
0
0
0
0
0
Kra 7 entre 97 - 94
190
0
1
1
3
5
Zone 3*
Kra Once
707
1
0
0
0
1
Cachivaches 85 - 105
21
0
0
0
0
0
Virrey
26
0
0
0
0
0
Zone 4*
Gobernación
801
1
1
0
2
4
Maloka
1027
0
14
0
7
21
Zone 5*
Parque de los Novios
184
0
0
1
1
2
Universidad Nacional
922
0
0
0
0
0
Zone 6
Candelaria
26
0
0
0
0
0
Plaza de Bolívar
4
0
0
0
0
0
Total
4116
2
18
2
13
35
*: places which had been positive in previous studies.
*: places which had been positive in previous studies.Most of the positive samples (n = 27) were obtained in July and November 2013,
coinciding with previous periods of high precipitation. Only few samples (n = 8) were
recovered during the dry season temperature and relative humidity was relatively
constant throughout the study period with no other obvious associations (Fig. 2).
Fig. 2
: positive isolates of Cryptococcus neoformans and
climatic parameters: precipitation (mms) and sunshine (h).
Description of clinical cases of cryptococcosis - A total of 55 surveys
were received during the study period, corresponding to new cases of cryptococcosis,
reported mainly in men (43 cases, 78.2%). Patients aged 16-79 years old were the most
affected (59.3% of the cases with a median of 43 years). The main risk factor was HIVinfection in 36 (65.5%) cases, other risk factors were diabetes and leukemia and chronic
renal failure. One patient presented with autoimmune disease (lymphoma) (Table II).
TABLE II
Clinical manifestations, pharmacological treatment and diagnosis of
Cryptococcosis cases in Bogotá, Colombia (2012-2015)
Characteristics
(n)
(%)
Sex
Male
43
78.2
Female
12
21.8
Clinical features
Headache
45
81.8
Fever
28
50.9
Nausea and vomiting
21
38.2
Confusion
18
32.7
Loss weight
17
30.9
Seizures
13
23.6
Meningeal signs
7
12.7
Cough
13
23.6
Visual alterations
8
14.5
Risk factors
HIV infection
36
65.5
Corticosteroids
4
9.1
Autoimmune disease
1
Diabetes
1
5.4
Others (leukemia, CT)
2
No risk factor
11
20
Type of diagnosis
Positive Culture(one strain was not
viable)*
27
49.1
Positive Culture and Antigen
2
3.6
Positive Culture and direct examination
17
31.0
Positive Culture, direct examination and
Antigen
4
7.3
Direct examination
2
3.6
Direct examination and antigen
3
5.4
Total
55
100
Type of antifungal used
Amphotericin B
26
47.3
Fluconazole
3
5.5
Combined
0
0
No theraphy
26
47.3
*: it was not possible to recover the strain.
*: it was not possible to recover the strain.The most common clinical manifestations are described in Table II, consisting mostly of headache and fever.From the patients, 47.2% were treated with antifungal agents, with amphotericin B being
the most common antifungal used (47.3%), followed by fluconazole (5.5%).
Neurocryptococosis was the most common clinical form of the disease. Laboratory
diagnosis was performed using the conventional methods of direct examination,
antigenemia and culture. In 49/55 cases, the isolate was recovered; in six cases it was
not possible to recover the strain and only medical history is described (Table II).Molecular characterisation - Molecular type determination revealed that
from the 84 isolates characterised (n = 49 clinical and n = 35 environmental), 79
isolates (94%) were C. neoformans var. grubii
molecular type VNI, 4 (4.8%) isolates VNII and 1 (1.2%) VNIV (Fig. 3).
Fig. 3
: characterisation of clinical and environmental isolates of
Cryptococcus neoformans typed by GTG5-PCR fingerprinting
(A) and RFLP-URA5 (B).
Of the two main groups identified, group I had a similarity of 48%, including isolates
of C. neoformans var. grubii molecular type VNI and
VNII. A subgroup of group 1 was identified, with an index of similarity between 50-100%,
containing all isolates belonging to the molecular type VNI. In subgroup A, 10
genetically indistinguishable clusters were identified (with 100% similarity),
containing five clusters of clinical and environmental isolates. Group II contained the
only VNIV clinical isolate recovered and the control strain with a 100% similarity. Four
clinical and one environmental isolates did not group with any of the other isolates
(Fig. 4).
Fig. 4
: GTG5-PCR fingerprinting dendrogram of the Cryptococcus
neoformans clinical and environmental isolates from Bogotá.
Dendrogram of the PCR-fingerprint from clinical (♥)and environmental isolates
(♦), Group (A), clinical and environmental isolations grouped with 100%
similarity index. Software GelCompar II version 4.0, tolerance % and
optimisation 1.5.
DISCUSSION
In Colombia, several studies have been performed to describe the environmental
importance of Cryptococcus, and the potential relation of environmental
and clinical isolates. In some of these studies, isolates of serotypes A, B and C have
been recovered, from different species of trees including Eucalyptus
sp, Ficus sp, C. ficifolia, T.
catappa, among others, similarly to the reports of other groups in countries
like Brazil and India (Randhawa et al. 2001,
Trilles et al. 2008).C. neoformans var. grubii serotype A was the only
species recovered in the environmental samples collected in this study, with a frequency
of 0.7 %. This positivity falls within that of the literature, where a frequency between
0.1-69% has been reported, confirming the same results obtained in other environmental
studies, and reinforcing the predominance of this species in the environment around the
world (Perfect et al. 1993, Randhawa et al. 2001, Escandón et
al. 2006, Trilles et al. 2008).In this study we found C. neoformans in places with high density of
trees, people and pigeons, distributed in the center and north-west of the city. In
other studies of Bogotá, authors reported a positivity from the environment of 7.9% for
C. neoformans (Granados &
Castañeda 2005). The yeast was recovered in five out of the six studied areas,
and from those, four were previously reported as positive in other studies (Escandón et al. 2006, Granados & Castañeda 2006), suggesting permanence and
colonisation of the fungus over time. Additionally, a new area was identified as
positive for C. neoformans.In this study C. gattii was not recovered, from clinical nor
environmental samples, which is in contrast to other studies reported in Bogotá were
C. gattii was isolated in 11.72% from C. ficifolia
samples (Escandón et al. 2010).This study reinforces the predominance of C. neoformans in
Eucalyptus tree species; as has been found in studies in Egypt
(Cogliati 2013), Brazil (Trilles et al. 2008) and Australia (Ellis & Pfeiffer 1990). The preference of C. neoformans
for this type of tree may be due to the specific characteristics of the wood, for
example due to the hollows, as suggested by Ellis and
Pfeiffer (1992).The months when the fungus was recovered coincide with previous periods of high
precipitation, confirming the findings reported by Granados and Castañeda (2005, 2006),
who analysed the presence of C. neoformans in environmental samples and
concluded that the fungus was most frequently recovered in the rainy season.In Colombia, cryptococcosis by C. neoformans var.
grubii has high morbidity and mortality, especially in HIV-positivepatients in (Escandón et al. 2010, Lizarazo et al. 2014). Chronic lung disease, cancer
and immune disorders such as neoplasia, HIV/AIDS, predispose patients to infection by
Cryptococcus (Hull & Heitman
2002). The latter is apparent in Colombian patients, in which risk factors
such as HIV infection, leukemia, diabetes and renal failure were presented (Escandón et al. 2010), as well as the predominance
of C. neoformans var. grubii (serotype A) (98.1%). The
finding in Colombia that var. grubii is the most common clinical
isolate correlates with the reports from around the world, as well as the association of
molecular type VNI with AIDSpatients (Escandón et al.
2006).Genotype VNI was identified in 94% of the environmental and clinical isolates, in
agreement with the distribution reported in South America (Meyer et al. 2003), Vietnam (Chau et
al. 2010), India (Jain et al. 2005),
Malaysia (Tay et al. 2010), China (Feng et al. 2008), Korea (Choi et al. 2010) and frequently recovered in the environment (Jain et al. 2005, Cogliati 2013). Molecular studies found a relation between clinical and
environmental isolates, reinforcing the hypothesis that infection is acquired by the
inhalation of infectious propagules present in the environment (Meyer et al. 2003, Trilles et al.
2008, Byrnes et al. 2009, Velagapudi et al. 2009). In this study, clinical and
environmental isolates were found to be between 48-100% similar. This is congruent with
other studies around the world, such as the reported in 2008 by Trilles et al. (2008), who found a similarity index of 50% in VNI,
being the most prevalent in 443 environmental and clinical isolates from Brazil. In the
same year Meyer reported a similarity index of 50.4% between clinical and environmental
isolates of C. neoformans var. grubii (Meyer et al. 2003).The search of C. neoformans and C. gattii in the
environment needs to be included as a routine practice, in those areas were
cryptococcosis cases are prevalent, as a tool that will help us identify colonised areas
which may represent increased exposure risks to the patients. The continuous finding of
the fungus both in the environment and in the patients of the capital city of Colombia
reinforces the need to direct our efforts into more active surveillance of the
disease.Ecological studies are relevant in the epidemiological study of this pathogen; therefore
the continuity of clinical research is important for ecological studies, the results of
which may allow us to determinate areas where the fungus can find favorable conditions
to develop in Colombia.
Authors: N Jain; B L Wickes; S M Keller; J Fu; A Casadevall; P Jain; M A Ragan; U Banerjee; B C Fries Journal: J Clin Microbiol Date: 2005-11 Impact factor: 5.948
Authors: María Francisca Colom; Ferry Hagen; Alfonso Gonzalez; Axelle Mellado; Neus Morera; Carlos Linares; David F García; Joaquín S Peñataro; Teun Boekhout; Manuel Sánchez Journal: Med Mycol Date: 2011-04-26 Impact factor: 4.076
Authors: Wieland Meyer; Alexandra Castañeda; Stuart Jackson; Matthew Huynh; Elizabeth Castañeda Journal: Emerg Infect Dis Date: 2003-02 Impact factor: 6.883
Authors: Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day Journal: BMC Infect Dis Date: 2010-07-09 Impact factor: 3.090
Authors: Ferry Hagen; M Francisca Colom; Daniëlle Swinne; Kathrin Tintelnot; Roberta Iatta; Maria Teresa Montagna; Josep M Torres-Rodriguez; Massimo Cogliati; Aristea Velegraki; Arjan Burggraaf; Alwin Kamermans; Johanna M Sweere; Jacques F Meis; Corné H W Klaassen; Teun Boekhout Journal: Emerg Infect Dis Date: 2012-10 Impact factor: 6.883
Authors: Crislaine Lambiase Calvete; Kevin Felipe Martho; Gabrielle Felizardo; Alexandre Paes; João Miguel Nunes; Camila Oliveira Ferreira; Marcelo A Vallim; Renata C Pascon Journal: PLoS One Date: 2019-01-25 Impact factor: 3.240